🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group

EntrackrEntrackr · 5m ago
Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group
Medial

Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group Lamark's proprietary ProteoStrong platform enables the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure. Biopharma startup Lamark Biotech has raised Rs 6.5 crore in a pre-Series A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Vinayender Tulla, Nita Roy, and Venkataraman KNK. Domain experts from IAN’s angel investors led the round. The Ahmedabad-based company had previously raised $41.3K in a seed funding round led by VIT-TBI and others. The fresh funds will be utilized to accelerate the development of thermostable insulin and expand the biologics platform for global access, Lamark said in a press release. Founded in 2018 by Vaibhav Bhatia, Lamark Biotech aims to reimagine drug delivery for chronic and life-altering diseases. Its proprietary ProteoStrong platform enables the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure. According to Lamark Biotech, it leverages the R&D base of Venture Center, NCL Innovation, and it is advancing a new class of temperature-resilient biologics that retain potency across extreme conditions—ideal for underserved regions where cold storage infrastructure is limited. With its lead program, InsulinStrong, Lamark is targeting the Rs 4,000 crore Indian insulin market and intends to expand across Southeast Asia and the UAE. In the next 24 months, it plans to file new international patents, begin early clinical trials, and build partnerships with pharma companies, CDMOs, and global health agencies.

1

Related News

Terafac raises Rs 6.5 Cr in pre-seed round led by Inuka Capital

EntrackrEntrackr · 3m ago
Terafac raises Rs 6.5 Cr in pre-seed round led by Inuka Capital
Medial

Terafac raises Rs 6.5 Cr in pre-seed round led by Inuka Capital Chandigarh-based AI-robotics startup Terafac has raised Rs 6.5 crore ($800K) in a pre-seed round led by Inuka Capital. Other investors include DEVC, Bharat Founders Fund, Innovation Mission Punjab, and select angels. The proceeds will be used for product innovation, market expansion, and hiring. Founded by Anubhi Khandelwal and Amrit Singh, Terafac has developed an AI-Vision platform that converts standard industrial robots into intelligent, self-adjusting machines. Its first product, WeldT, automates welding using computer vision to handle high product variations. The startup plans to expand its solution across tasks like gluing, painting, and inspection. Terafac operates on a "Software-as-a-Skill" model and targets 80 deployments across 20 customers in the next year. Its business model revolves around providing AI-based manufacturing automation tools to OEMs and factories, aiming to reach Rs 8 crore in ARR by FY26.

Ambulance startup Dial4242 raises Rs 9 Cr in pre-Series A round

EntrackrEntrackr · 4m ago
Ambulance startup Dial4242 raises Rs 9 Cr in pre-Series A round
Medial

Ambulance tech startup Dial4242 has raised Rs 9 crore (around $1.04 million) in its pre-Series A funding round led by IAN Group, with participation from BioAngels, IIM Bangalore’s NSRCEL, and other notable angels. Earlier in September 2023, Dial4242 had raised Rs 1 crore in its seed round led by investors G Vamshi Raju, Starfish Ventures, and a clutch of angel investors based in Hyderabad. The proceeds will be used to scale operations, improve ambulance turnaround time from 12 to under 8 minutes, expand medical centers in underserved areas, strengthen tech infrastructure, and boost leadership hiring. Founded in 2016 by Jeetendra Lalwani, Nilesh Mahambre, and Atin Verma, Dial4242 runs a tech-enabled ambulance network in India, covering over 850 cities. Its platform enables real-time tracking, automated dispatch, and 24x7 emergency coordination. With a tech-first, asset-light model, the startup has partnered with firms like Amazon, Zomato, and Swiggy to provide emergency care access to gig workers. The brand also plans to launch a low-cost membership model offering free ambulance access, deepen hospital partnerships, and further improve emergency response standards. Dial4242 competes with the likes of MeduLance, HelpNow, ESahai, AmbiPalm and Mo Ambulance among others in the ambulance booking segment.

Argos Watches raises Rs 6.5 Cr in Angel round

EntrackrEntrackr · 8m ago
Argos Watches raises Rs 6.5 Cr in Angel round
Medial

Argos Watches raises Rs 6.5 Cr in Angel round Indian luxury watch brand Argos Watches has raised Rs 6.5 crore (around $780K) in an angel funding round, valuing the company at Rs 45 crore ($5.4 million) from a group of high-net-worth Indian investors. The proceeds will be used to create new products, build brand awareness, and grow online. Argos aims to double its revenue this year. Founded by Mr. M. Shahiwala, Argos brand offers high-quality, vintage-style automatic and hand-wound watches at affordable prices. It sells its watches only through its website, using a direct-to-consumer model to offer an easy buying experience. Its watches cost between Rs 8,000 and Rs 20,000. Its Apollo series and flagship Olympus watch, a mechanical watch with a power reserve indicator, have gained popularity among Indian watch enthusiasts. As of 2025, Argos remains bootstrapped, with an estimated revenue of around $580,000 annually. The brand plans to launch more models with advanced features while continuing to build its brand through community engagement and digital presence.

MiClient raises seed round from IAN Group, others

EntrackrEntrackr · 1y ago
MiClient raises seed round from IAN Group, others
Medial

MiClient, an AI-driven B2B sales enablement platform, has raised Rs 3.9 crore in its seed funding round led by IAN Group with participation from Anicut, GSF, RTAF, and Keiretsu. Vikas Kuthiala and Pratik Mathurkar from IAN led the round. The round follows an initial pre-seed investment in October 2023 from 100x.VC. The proceeds will be used to build a stronger team and expand market presence across more geographies in India. In addition to market expansion, MiClient is developing an AI-based model to create quotations and invoices in seconds, further streamlining the sales process for its users. Led by Swati Sharma, MiClient’s easy-to-use CPQ platform helps sales teams close deals three times faster, with the average deal now closing in just 10 days. Expanding further into India’s industrial hubs, MiClient is executing a feet-on-the-street go-to-market strategy. MiClient is expanding into more industrial hubs across India using a direct sales approach. With over 150 customers and over 1,500 users, the company serves SMEs, particularly in the B2B manufacturing sector, with a user-friendly platform.

Genexis Biotech raises Rs 4 Cr in seed round led by GVFL

EntrackrEntrackr · 4m ago
Genexis Biotech raises Rs 4 Cr in seed round led by GVFL
Medial

Genexis Biotech raises Rs 4 Cr in seed round led by GVFL Vadodara-based bio-manufacturing startup Genexis Biotech has raised Rs 4 crore in a seed funding round led by GVFL, with participation from Benzai10. The proceeds will be used to scale bioreactor capacity, build downstream processing infrastructure, launch new recombinant proteins and enzymes, and strengthen compliance, sales, and distribution functions. Genexis Biotech develops animal-origin-free recombinant proteins using precision fermentation, catering to sectors like biopharma, food-tech, and cell culture. The startup operates a certified Class 10,000 facility and is setting up a GMP-compliant unit. It has introduced recombinant peptidases such as amino peptidase and enterokinase, and plans to launch recombinant transferrin and albumin. In the past year, Genexis established partnerships with pharmaceutical companies and biotech firms, signed an MoU with the Gujarat government, and received client orders for alternative protein formulations. It showcased its portfolio at Global Bio-India 2024 and aims to enter the regulated biotech export market, develop encapsulated formulations for the cosmetics industry, and collaborate with CDMOs, academic labs, and biopharma firms. Genexis Biotech focuses on scalable, ethical biomolecule production. GVFL has backed the company as part of its investment thesis across deeptech and biotech innovation.

Agraga raises Rs 100 Cr in pre-Series B led by Bajaj Finserv Group

EntrackrEntrackr · 10d ago
Agraga raises Rs 100 Cr in pre-Series B led by Bajaj Finserv Group
Medial

Agraga raises Rs 100 Cr in pre-Series B led by Bajaj Finserv Group Digital freight forwarder Agraga has raised Rs 100 crore (around $12 million) in its pre-Series B round led by Bajaj Finserv Group, with participation from existing investor IvyCap Ventures and select global angel backers. Agraga had earlier raised Rs 70 crore in its Series A round in May 2023, led by IvyCap Ventures with participation from Alteria. The proceeds will be used to expand its cross-border logistics platform, strengthen its LCL (Less-than-Container Load) vertical, scale automation and visibility tools, and deepen its presence across major export hubs. Founded in 2021, Agraga provides a unified platform that integrates freight booking, customs, warehousing, and embedded financial services. The firm aims to simplify cross-border logistics for MSMEs and mid-market enterprises by offering real-time pricing, tracking, and compliance workflows. Agraga claims to have built its stack around four layers which includes discovery, tracking, execution, and data-driven decision-making. Agraga serves more than 700 customers and 1,000 vendors across 40 global trade lanes. It also partners with financial institutions including ICICI Bank and IDFC First Bank. Its subsidiary Byteport Logistics focuses on channel-partner aggregation for MSME and LCL customers. Bajaj Finserv backs Indian startups through its corporate venture arm, Bajaj Finserv Ventures, and its newer alternative investment subsidiary, with a focus on fintech, healthcare and technology.

Download the medial app to read full posts, comements and news.